Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Alliant Energy Q2 Earnings Lag Estimates, Revenues Increase Y/Y
Alliant Energy Q2 Earnings Lag Estimates, Revenues Increase Y/Y

Alliant Energy Corporation LNT reported second-quarter 2026 earnings of 65 cents per share, which missed the Zacks Consensus Estimate of 66 cents by 1.52%. The bottom line declined 4.4% from 68

Weyerhaeuser Q2 Earnings & Sales Top, Adjusted EBITDA Down Y/Y
Weyerhaeuser Q2 Earnings & Sales Top, Adjusted EBITDA Down Y/Y

Weyerhaeuser Company WY reported better-than-expected second-quarter 2026 financial results with adjusted earnings and net sales topping the Zacks Consensus Estimate. Year over year, the bottom line

RES Q2 Earnings Beat Estimates on Better Job Mix, Revenues Miss
RES Q2 Earnings Beat Estimates on Better Job Mix, Revenues Miss

RPC, Inc. RES reported second-quarter 2026 adjusted earnings of 8 cents per share, which beat the Zacks Consensus Estimate of 4 cents by 100%. The bottom line also improved from the year-ago

PBF Energy Q2 Earnings Beat Estimates on Higher Refining Margins: https://staticx-tuner.zacks.com/images/articles/main/b5/159583.webp
PBF Energy Q2 Earnings Beat Estimates on Higher Refining Margins

PBF Energy Inc. PBF reported second-quarter 2026 adjusted earnings of $6.22 per share, reversing the year-ago loss of $1.03. The bottom line beat the Zacks Consensus Estimate of $4.05 by 53.6%.

First Solar's Q2 Earnings Beat Estimates, Revenues Decrease Y/Y
First Solar's Q2 Earnings Beat Estimates, Revenues Decrease Y/Y

First Solar, Inc. FSLR reported second-quarter 2026 earnings of $3.92 per share, which beat the Zacks Consensus Estimate of $2.74 by 43.1%. The bottom line increased 23.3% from $3.18 in the year-ago

MRNA Q2 Earnings Meet, Stock Down on Norovirus Vaccine Setback
MRNA Q2 Earnings Meet, Stock Down on Norovirus Vaccine Setback

Moderna MRNA reported a second-quarter 2026 loss of $1.97 per share, in line with the Zacks Consensus Estimate. The loss narrowed 7.5% from $2.13 a year ago.

Total revenues in the second quarter

MKL Q2 Earnings Miss Estimates on Weak Industrial, Financial Units: https://staticx-tuner.zacks.com/images/articles/main/30/172914.webp
MKL Q2 Earnings Miss Estimates on Weak Industrial, Financial Units

 Markel Group Inc. MKL reported second-quarter 2026 adjusted operating income of $19.5 per share, which missed the Zacks Consensus Estimate by 10.4%. The bottom line deteriorated 25% year over year.

Linc Ab

WKN: A3CQZ5 / Name: Linc Ab / Stock / ? /

€6.66
0.760%